Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.
Will a New Study Force Changes in Drug Law?
Corporate Accountability and WorkPlace:
How to Reframe the Poverty Debate
Margy Waller
Democracy and Elections:
More Unfinished 2008 Election Business: Verifiable Vote Counts
Steven Rosenfeld
DrugReporter:
A New Approach to Drugs Would Save New York Hundreds of Millions of Dollars
Gabriel Sayegh
Election 2008:
Franken Lawyer: "We Are Going To Win"
Sam Stein
Environment:
Soil Not Oil: Why We Need to Kick Petroleum Out of Our Farms
Vandana Shiva
ForeignPolicy:
Are Key Obama Advisors in Tune with Neocon Hawks Who Want War with Iran?
Robert Dreyfuss
Health and Wellness:
Renowned Psychiatrists on Drug Company Payrolls
Bruce E. Levine
Hurricane Katrina:
From the Bayou to Baghdad: Mission Not Accomplished
Amy Goodman
Immigration:
Immigration Reform After Bush: Let's Put an End to Punitive Policies
Roberto Lovato
Media and Technology:
Born Digital: Understanding the First Generation of Digital Natives
Doron Taussig
Movie Mix:
Love Bites: What Sexy Vampires Tell Us About Our Culture
Sarah Seltzer
Reproductive Justice and Gender:
SNL's Amy Poehler: Smart Girls Have More Fun
Marianne Schnall
Rights and Liberties:
Mormon Homophobia: Up Close and Personal
Sheldon Rampton
Sex and Relationships:
9 Ways to Halt the Right Wing Culture Wars and Bring Sanity to Sexual Policy
David Rosen
War on Iraq:
Would You "Shoot an Iraqi" in Cyberspace?
Gabriel Thompson
Water:
Is the Latest Eco-Term Just Corporate Hype?
Jeff Conant
On March 8, a high-powered British commission recommended tossing that country's law on illegal drugs onto the scrap heap and starting over again. Given that the U.S. Controlled Substances Act parallels the British Misuse of Drugs Act in important ways, the suggestion deserves attention in America as well.
Indeed, it would be a fine start if Americans could simply begin the sort of rational, thoughtful debate on drug policy that the British seem to be having. If we could manage such a thing, we might start changing illogical and unscientific laws that now lead to more U.S. arrests for marijuana possession than for all violent crimes combined.
The RSA Commission on Illegal Drugs, Communities and Public Policy, was convened by the Royal Society for the Encouragement of Arts, Manufactures and Commerce, a respected think tank with a 250-year history. After two years of research, this panel of experts and laypeople came to a number of conclusions so sensible and so obvious that it's astonishing how consistently our elected leaders have avoided confronting them. In particular:
As an example of the sort of harms index they envision, the RSA Commission points to an index developed by a pair of British scientists, David Nutt and Colin Blakemore, and published in a House of Commons report last year.
Based on scientific evaluations of physical harms (e.g., acute and chronic toxicity), likelihood of dependence, and social harms (including damage done to others, health care costs, etc.), Nutt and Blakemore ranked 20 different classes of drugs, both legal and illegal. Not surprisingly, heroin was at the top of the harm scale, followed by cocaine and barbiturates. Alcohol and tobacco were rated as significantly more harmful than marijuana and several other illegal substances.
While not specifically endorsing the Nutt/Blakemore index, the RSA Commission clearly considered these rankings a good example of what they have in mind, using them as a starting point for illustrations of how such an index might translate into law. Marijuana, they wrote, "should continue to be controlled. But its position on the harms index suggests that the form this control takes might have to correspond far more closely with the way in which alcohol and tobacco are regulated."
See more stories tagged with: drugs, marijuana, legalization, britain, drug law
Bruce Mirken is communications director for the Marijuana Policy Project.
Liked this story? Get top stories in your inbox each week from AlterNet! Sign up now »